CHPD21 License Agreement

The authors and publisher have made every effort to ensure that information presented in this publication is in accordance with current recommendations and practice at the time of publication. However, due to changing government regulations, continuing research, and changing information concerning drug therapy and reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage, or for added precautions. The authors and publisher disclaim any responsibility for any consequences which may follow from the use of information presented in the Clinical Handbook of Psychotropic Drugs, including the Patient Information Sheets.

Copyright Information
The Patient Information Sheets accompanying the Clinical Handbook of Psychotropic Drugs are protected under international copyright law. The unauthorized use or distribution of copyrighted or proprietary content is illegal and could subject anyone doing so to substantial damages. The user agrees to recognize and uphold the copyright.

License Agreement
The user is granted permission to produce printouts of the Patient Information Sheets to hand out to their patients in the course of  their practice work. Producing printouts and storing a backup copy of the Patient Information Sheets on another device is permitted for personal practice use only.

Other than as stated in this License Agreement, you may not copy, print, modify, remove, delete, augment, add to, publish, transmit, sell, resell, create derivative works from, or in any way exploit any of the Patient Information Sheets’ content, in whole or in part, and you may not aid or permit others to do so.

You shall not:

  1. rent, assign, timeshare, distribute, or transfer all or part of the Patient Information Sheets or any rights granted by this License Agreement to any other person;
  2. duplicate the Patient Information Sheets, except for practice use and for reasonable backup copies;
  3. remove any proprietary or copyright notices, digital watermarks, labels, or other marks from the Patient Information Sheets or their contents;
  4. transfer or sublicense title to the Patient Information Sheets to any other party.